BiotechTube
CheminPharma

CheminPharma

Cambridge, United States· Est.
cheminpharma.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.8M

Overview

CheminPharma is a private, revenue-generating service and product provider supporting early-stage drug discovery and development. The company leverages its expertise in medicinal and process chemistry to offer custom synthesis, lead optimization, and analytical development services, while also commercializing proprietary research tools like its exclusive AquaShield-1 reagent. Its business model is built on serving as a critical partner to pharmaceutical and biotech companies, bridging a technical gap in the R&D value chain. While not developing its own therapeutic pipeline, CheminPharma's growth is tied to the overall innovation and outsourcing trends within the small molecule drug discovery market.

Small MoleculesDrug Delivery

Technology Platform

Integrated chemistry expertise in medicinal and process chemistry, complemented by proprietary research reagents like AquaShield-1, to provide end-to-end small molecule discovery and development services.

Funding History

1
Total raised:$1.8M
Seed$1.8M

Opportunities

Growing demand for specialized chemistry outsourcing from virtual and small biotech firms, particularly in hubs like Boston/Cambridge.
The proprietary reagent AquaShield-1 provides a scalable product revenue stream and demonstrates innovative capability, allowing for potential expansion of a proprietary tools portfolio.
The sustained importance of small molecules in drug discovery, including complex new modalities, ensures a large addressable market.

Risk Factors

Revenue is vulnerable to client concentration and cyclical downturns in biotech R&D funding.
Faces intense competition from large global CROs and other boutique chemistry firms, pressuring pricing and requiring constant demonstration of superior quality.
Reliance on key personnel for scientific expertise and business development creates employee retention and execution risks.

Competitive Landscape

CheminPharma competes in the fragmented chemistry CRO and research reagents market. Key competitors range from large, full-service CROs (e.g., Labcorp, WuXi AppTec) to specialized chemistry service providers and reagent suppliers (e.g., Sigma-Aldrich/MilliporeSigma, Combi-Blocks). Its differentiation hinges on high-touch, expert-driven service for complex chemistry problems and exclusive tools, rather than competing on scale or low cost.

More companies in United States →